Annual CFI
$44.98 M
+$71.27 M+271.08%
December 31, 2023
Summary
- As of February 18, 2025, ALGS annual cash flow from investing activities is $44.98 million, with the most recent change of +$71.27 million (+271.08%) on December 31, 2023.
- During the last 3 years, ALGS annual CFI has risen by +$12.23 million (+37.33%).
- ALGS annual CFI is now at all-time high.
Performance
ALGS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$10.40 M
-$29.59 M-74.00%
September 30, 2024
Summary
- As of February 18, 2025, ALGS quarterly cash flow from investing activities is $10.40 million, with the most recent change of -$29.59 million (-74.00%) on September 30, 2024.
- Over the past year, ALGS quarterly CFI has stayed the same.
- ALGS quarterly CFI is now -74.00% below its all-time high of $39.99 million, reached on June 30, 2024.
Performance
ALGS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$38.26 M
+$10.41 M+21.38%
September 30, 2024
Summary
- As of February 18, 2025, ALGS TTM cash flow from investing activities is -$38.26 million, with the most recent change of +$10.41 million (+21.38%) on September 30, 2024.
- Over the past year, ALGS TTM CFI has stayed the same.
- ALGS TTM CFI is now -142.95% below its all-time high of $89.08 million, reached on June 30, 2023.
Performance
ALGS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ALGS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +271.1% | 0.0% | 0.0% |
| 3 y3 years | +37.3% | -48.0% | -170.7% |
| 5 y5 years | - | -48.0% | -170.7% |
ALGS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +271.1% | -74.0% | +111.7% | -142.9% | +56.0% |
| 5 y | 5-year | at high | +271.1% | -74.0% | +111.7% | -142.9% | +56.0% |
| alltime | all time | at high | +271.1% | -74.0% | +111.7% | -142.9% | +56.0% |
Aligos Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $10.40 M(-74.0%) | -$38.26 M(-21.4%) |
| Jun 2024 | - | $39.99 M(-145.1%) | -$48.66 M(-23.5%) |
| Mar 2024 | - | -$88.64 M(>+9900.0%) | -$63.65 M(-241.5%) |
| Dec 2023 | $44.98 M(-271.1%) | -$7000.00(-22.2%) | $44.98 M(-20.5%) |
| Sep 2023 | - | -$9000.00(-100.0%) | $56.59 M(-36.5%) |
| Jun 2023 | - | $25.00 M(+25.1%) | $89.08 M(+64.7%) |
| Mar 2023 | - | $19.99 M(+72.3%) | $54.10 M(-305.8%) |
| Dec 2022 | -$26.29 M | $11.60 M(-64.3%) | -$26.29 M(-51.6%) |
| Sep 2022 | - | $32.48 M(-425.6%) | -$54.38 M(-37.4%) |
| Jun 2022 | - | -$9.98 M(-83.5%) | -$86.90 M(+29.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$60.40 M(+266.6%) | -$67.08 M(-2319.6%) |
| Dec 2021 | $3.02 M(-90.8%) | -$16.48 M(>+9900.0%) | $3.02 M(-91.2%) |
| Sep 2021 | - | -$40.00 K(-100.4%) | $34.44 M(-43.7%) |
| Jun 2021 | - | $9.85 M(+1.6%) | $61.13 M(-7.7%) |
| Mar 2021 | - | $9.69 M(-35.1%) | $66.22 M(+102.2%) |
| Dec 2020 | $32.76 M(+382.3%) | $14.94 M(-44.0%) | $32.76 M(+83.8%) |
| Sep 2020 | - | $26.66 M(+78.5%) | $17.82 M(-301.6%) |
| Jun 2020 | - | $14.93 M(-162.8%) | -$8.84 M(-62.8%) |
| Mar 2020 | - | -$23.77 M | -$23.77 M |
| Dec 2019 | $6.79 M | - | - |
FAQ
- What is Aligos Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Aligos Therapeutics?
- What is Aligos Therapeutics annual CFI year-on-year change?
- What is Aligos Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly CFI year-on-year change?
- What is Aligos Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Aligos Therapeutics?
- What is Aligos Therapeutics TTM CFI year-on-year change?
What is Aligos Therapeutics annual cash flow from investing activities?
The current annual CFI of ALGS is $44.98 M
What is the all time high annual CFI for Aligos Therapeutics?
Aligos Therapeutics all-time high annual cash flow from investing activities is $44.98 M
What is Aligos Therapeutics annual CFI year-on-year change?
Over the past year, ALGS annual cash flow from investing activities has changed by +$71.27 M (+271.08%)
What is Aligos Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ALGS is $10.40 M
What is the all time high quarterly CFI for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly cash flow from investing activities is $39.99 M
What is Aligos Therapeutics quarterly CFI year-on-year change?
Over the past year, ALGS quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Aligos Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ALGS is -$38.26 M
What is the all time high TTM CFI for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM cash flow from investing activities is $89.08 M
What is Aligos Therapeutics TTM CFI year-on-year change?
Over the past year, ALGS TTM cash flow from investing activities has changed by $0.00 (0.00%)